Universal reference book for medicines
Name of the drug: UZARA ® (UZARA)

Active substance: nonappropriate

Type: Antidiarrhoeal phytopreparation

Manufacturer: STADA Arzneimittel (Germany)
Composition, form of production and packaging
The syrup is
transparent to opalescent, from yellowish to brownish in color, with a characteristic odor.

1 ml

dry extract of the root of Usara (4.5-6.2: 1) 7.56 mg

Excipients: propylene glycol, macrogolglycerol hydroxy stearate, cola flavor, dextrose (glucose) monohydrate, dextrose (glucose) liquid, purified water.

100 ml - bottles of dark glass (1) complete with a measuring cap - packs cardboard.

INSTRUCTION FOR THE SPECIALIST.

Description of the drug approved by the manufacturer for the printed edition of 2008.

PHARMACHOLOGIC EFFECT

An antidiarrhoeal agent of plant origin.
The mechanism of the anti-peristaltic action of Uzara is based on the stimulation of the sympathetic nervous system, resulting in a weakening of the intestinal motility.
In addition to suppressing the motility of the digestive tract, Uzara has antispasmodic, antisecretory, astringent and enveloping effect.

INDICATIONS

Nonspecific acute and chronic diarrhea:

- diarrhea associated with allergic reactions;

- diarrhea caused by psychoemotional factors;

- Diarrhea caused by impaired metabolism and absorption of nutrients;

- "diarrhea of ​​travelers", caused by a change in diet and the usual diet.

As an aid for diarrhea of ​​infectious genesis.

DOSING MODE

Inside, regardless of food intake.

Adults: the initial dose on the first day - 25 ml of syrup once, in the following days - 5 ml 3-6 times / day until the normalization of the stool.

Children of school age (from 7 to 16 years): the initial dose on the first day of 5-7 ml of syrup, in the following days 3-4 ml 3-6 times / day.

Children of preschool age (from 2 to 6 years): 1-2 ml of syrup 3-6 times / day.

Children from 1 to 2 years: 0.5 ml syrup 3 times / day.

SIDE EFFECT

Allergic reactions.

CONTRAINDICATIONS

- treatment with cardiac glycosides;

- Pregnancy;

- lactation period;

- Children's age up to 1 year;

hypersensitivity to the components of the drug.

PREGNANCY AND LACTATION

In experimental studies of teratogenic, mutagenic properties, Uzara was not identified.
Until now, there have been no reports of any developmental defects in the use of the drug.
Since the clinical experience of using the drug in pregnant and lactating women is very limited, Usara's use during pregnancy and lactation is not shown.

SPECIAL INSTRUCTIONS

If the duration of diarrhea exceeds 2 days, it is accompanied by high body temperature, and if there are impurities in the stool, you should immediately consult a doctor.

Use in Pediatrics

In children, the drug should be administered under the supervision of a doctor to avoid an overdose.

In children under 6 years of age, it is essential to use oral rehydration drugs as the main therapy.
The course of treatment should not exceed 7 days.
DRUG INTERACTION

At simultaneous application with preparations of calcium, saluretic or at long therapy by preparations of a cortisol occurrence of infringements of a warm rhythm is possible.

TERMS OF RELEASE FROM PHARMACY

On prescription.

TERMS AND CONDITIONS OF STORAGE

Store at a temperature not exceeding 25 ° C.
Keep out of the reach of children. Shelf life - 5 years.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Rambler's Top100
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!